Semaglutide
Semaglutide in Treatment of Obesity
Novo Nordisk · Phase 3 · Completed · Enrollment 462
| Arm | Nausea | Vomiting | Diarrhea | Discontinuation | Deaths |
|---|---|---|---|---|---|
| HD1916 | n/r | n/r | n/r | n/r | n/r |
| semaglutide | n/r | n/r | n/r | n/r | n/r |
A count stays a count. This page does not turn a count into a percent.